Loading chat...
MO HB1874
Bill
Status
2/13/2014
Primary Sponsor
Chris Molendorp
Click for details
AI Summary
-
Repeals and replaces section 376.823, RSMo, regarding pharmaceutical company rebate programs
-
Exempts pharmaceutical company rebate programs from section 191.905 regulations
-
Permits pharmaceutical companies to provide partial rebates of private health insurance co-payments and coinsurance to patients with multiple sclerosis, cancer, or other chronic, potentially disabling, or life-threatening conditions
-
Limits rebate eligibility to patients prescribed disease-managing medicines with no generic equivalents
Legislative Description
Allows patients with cancer who have been prescribed disease-managing medicines to receive a partial rebate of their private health insurance co-payments or coinsurance
Last Action
Referred: Health Insurance(H)
2/25/2014